Bulletin
Investor Alert

Aug. 3, 2020, 3:59 a.m. EDT

Coronavirus Business Impact: Antiretroviral Drugs Market Report 2020-2023| Industry Trends And Analysis

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Aug 03, 2020 (AmericaNewsHour) -- Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of antiretroviral market. The report analyses the Antiretroviral Market By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others). The report analyses the antiretroviral market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa) for the historical period of 2013-2017 and the forecast period of 2018-2023. This report also includes drug sales forecast for some antiretroviral drugs.

According to Azoth Analytics research report "Global Antiretroviral Market: Analysis By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others), By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa), Drug Forecast (2019 Edition): Forecast to 2023", the antiretroviral market is projected to display a robust growth represented by a CAGR of 4.70% during 2018 - 2023.

The Final Report will cover the impact analysis of COVID-19 on this industry:

Download Sample of This Strategic Report: 
https://www.kennethresearch.com/sample-request-10086135

Over the recent years,  Antiretroviral drugs market  has been witnessing growth on account of several driving factors including growing prevalence of HIV AIDS, growing antiretroviral treatment coverage rate, and increase in availability of novel drugs with better efficacy. Moreover, factors such as growing medical spending, favorable steps by government of various countries, decreased cost of treatment, improved diagnosis rate, and rise in the favorable programs to provide diagnosis and treatment facilities to the unmet patient population has been driving the market growth of antiretroviral drugs. In addition, increasing uptake of INSTI based regimens, increasing awareness regarding HIV care and treatment procedures, new drug launches, and improved R&D pipeline are anticipated to fuel the market growth in forecasted period. However, growing portfolio of generic antiretroviral drugs is expected impact the overall market growth.

In this research report, the market is segmented on the basis of drug type. By drug type, the multi-class drug combinations are predicted to hold their dominant position in the market, especially Gilead Sciences product Biktarvy and ViiV Healthcare product Triumeq are expected to give more traction to the market. Amongst the regions, North America accounts for the largest regional share in the global antiretroviral market in 2017. The largest share of North America is attributed to high ART coverage rate and more emphasis towards prescribed branded drugs.

The report titled "Global Antiretroviral Market: Analysis By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others), By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa), Drug Forecast (2019 Edition): Forecast to 2023" has covered and analysed the potential of antiretroviral drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the antiretroviral market. Additionally, the report also highlights market entry strategies for various companies across the globe along with drug sales forecast analysis.

Scope of the Report

Global Antiretroviral Drugs Market (actual period:2013-2017)(forecast period:2018-2023)
? Antiretroviral Drugs Market- Size, Growth, Forecast
? Analysis By Drug Type - Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others. 
? Drug Sales Forecast: 
o Multi-Class Drugs Combination: Juluca(R), Triumeq(R), Genvoya(R), Odefsey(R), Stribild(R), Biktarvy(R).
o Nucleoside Reverse Transcriptase Inhibitors: Epzicom(R)/ Kivexa(R).
o Non-Nucleoside Reverse Transcriptase Inhibitors: Edurant(R).
o Protease Inhibitors: PREZISTA (R) /PREZCOBIX(R) /REZOLSTA (R).
o Integrase Strand Transfer Inhibitors: Tivicay(R), Isentress/Isentress HD(R).
o CCR5 Inhibitor: Selzentry(R)/ Celsentri(R).

Regional Antiretroviral Drugs Market - North America, Europe, Asia Pacific, Rest of the World (actual period:2013-2017)(forecast period:2018-2023)
? Antiretroviral Drugs Market- Size, Growth, Forecast
? Analysis By Drug Type - Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others. 

Country Analysis - U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa (actual period:2013-2017)(forecast period:2018-2023)
? Antiretroviral Drugs Market- Size, Growth, Forecast
? Analysis By Drug Type - Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others. 

Other Report Highlights
? Product Sales Forecast.
? Market Dynamics - Drivers and Restraints.
? Market Trends.
? Porter Five Forces Analysis.
? SWOT Analysis.
? Company Analysis - Gilead Sciences Inc., ViiV Healthcare, Bristol-Myers Squibb, AbbVie Inc., Boehringer Ingelheim, Johnson & Johnson, Merck & Co., Cipla, Mylan.

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research. 

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products' demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research

Email:   Sales@kennethresearch.com

Phone: +1 313 462 0609

The post Coronavirus Business Impact: Antiretroviral Drugs Market Report 2020-2023| Industry Trends And Analysis appeared first on America News Hour .

COMTEX_368787365/2606/2020-08-03T03:58:46

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.